EGRX- Eagle Pharmaceuticals, Inc.
Eagle Pharmaceuticals, Inc. (EGRX) has 0 insiders with recent SEC Form 4 filings, including 1 buy and 40 sells. EGRX is classified in the Pharmaceuticals industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
Activity
Buys and sells only
Transactions
10 filings · page 5
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2016 | Proquest Investments Iv, L.P. | 10% Owner | Sell | 22,100 | $70.06 | $1,548,326.00 | -0.5% | |
| Sep 29, 2016 | Proquest Investments Iv, L.P. | 10% Owner | Sell | 77,900 | $70.04 | $5,456,116.00 | -1.7% | |
| Sep 21, 2016 | Proquest Investments Iv, L.P. | 10% Owner | Sell | 99,795 | $66.17 | $6,603,416.03 | -1.1% | |
| Sep 8, 2016 | Proquest Investments Iv, L.P. | 10% Owner | Sell | 70,925 | $62.50 | $4,432,862.85 | -0.4% | |
| Aug 24, 2016 | Proquest Investments Iv, L.P. | 10% Owner | Sell | 28,870 | $63.00 | $1,818,671.06 | -0.3% | |
| Aug 17, 2016 | Proquest Investments Iv, L.P. | 10% Owner | Sell | 99,795 | $61.36 | $6,123,170.01 | -0.3% | |
| May 13, 2016 | Proquest Management LLC | 10% Owner | Sell | 17,980 | $40.72 | $732,061.60 | -15.8% | |
| Apr 1, 2016 | Tarriff Scott | President And CEO | Sell | 30,765 | $40.63 | $1,249,981.95 | -2.2% | |
| Mar 15, 2016 | Graves Michael | Director | Buy | 1,000 | $56.73 | $56,730.00 | New | |
| Mar 1, 2016 | Tarriff Scott | President And CEO | Sell | 19,780 | $63.20 | $1,250,027.96 | -0.7% |